Literature DB >> 18027408

Molecular targets and cancer therapeutics.

Lucile Serfass, Carla Van Herpen, Mahasti Saghatchian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18027408

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells.

Authors:  Li Zhang; Yi Zhang; Xiao-yuan Liu; Zheng-hong Qin; Jin-ming Yang
Journal:  Acta Pharmacol Sin       Date:  2011-01-31       Impact factor: 6.150

2.  Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.

Authors:  Xiao-Yuan Liu; Li Zhang; Jianping Wu; Lei Zhou; Yi-Jie Ren; Wei-Qiong Yang; Zi-Jun Ming; Bo Chen; Jianrong Wang; Yi Zhang; Jin-Ming Yang
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

3.  Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.

Authors:  Lin Liu; PeiYu Huang; ZhiHui Wang; Nan Chen; Con Tang; Zhong Lin; PeiJian Peng
Journal:  BMC Cancer       Date:  2016-10-19       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.